Chiron Real Estate Inc. 2025 Annual Report (10-K) Summary
Business Context and Reporting Period
This filing covers the fiscal year ended December 31, 2025. Chiron Real Estate Inc. (formerly Global Medical REIT Inc., renamed February 23, 2026) is an internally managed REIT focused on acquiring healthcare facilities leased to physician groups and healthcare systems. The portfolio consists of 189 buildings with approximately 5.1 million leasable square feet and $118.8 million in annualized base rent. The company completed a one-for-five reverse stock split on September 19, 2025.
Key Financial Metrics
- Revenue: Total revenue was $148.2 million, an increase of $9.4 million (6.8%) from 2024, driven by acquisitions and expense recoveries.
- Net Income (Loss): The company reported a net loss of $6.9 million for 2025, compared to net income of $6.7 million in 2024. This decline was primarily due to $13.0 million in impairment charges on investment properties.
- Non-GAAP Measures:
- Funds From Operations (FFO): $57.6 million ($3.97 per share/unit).
- Core FFO: $65.8 million ($4.53 per share/unit).
- Funds Available for Distribution (FAD): $52.4 million.
- Debt and Liquidity:
- Total indebtedness: Approximately $655 million (Credit Facility net of issuance costs: $652.7 million; Notes payable: $1.2 million).
- Cash and cash equivalents: $11.9 million as of December 31, 2025.
- Weighted average interest rate: 3.74%.
- Dividends: Total common dividends paid were $3.30 per share for the year (reduced from $4.20 in 2024 due to rate cuts in Q2-Q4 2025).
Material Changes vs. Prior Period
- Impairment Charges: Recognized $13.0 million in impairment losses on three properties (Aurora, IL; Melbourne, FL; Derby, KS) due to contractual sale prices below carrying values. This was a significant increase from $1.7 million in 2024.
- Acquisitions and Dispositions: Acquired a five-property portfolio for $69.6 million. Completed seven dispositions generating $23.0 million in net proceeds and a $1.5 million gain.
- Capital Structure: Issued 2.05 million shares of Series B Preferred Stock, raising $51.3 million in gross proceeds, primarily used to repay revolver borrowings.
- Interest Expense: Increased to $31.8 million from $28.7 million in 2024 due to higher interest rates and net borrowings.
Guidance, Outlook, and Risks
Recent Developments:
- White Rock Medical Center Bankruptcy: In January 2026, tenant White Rock Medical Center filed for Chapter 11. The company has a receivable of approximately $1.4 million and is assisting with property tax obligations while awaiting lease affirmation.
- Active Adult Joint Venture: Entered a joint venture in January 2026 to develop a 132-unit active adult community in Minnesota.
Outlook and Risks:
- Interest Rate Environment: While rates trended lower in late 2025, the company faces increased interest expense on new hedges effective May 2026 (rates 3.24%–3.32%) compared to previous swaps (1.36%).
- Tenant Concentration: Top three tenants (LifePoint Health, Encompass Health, Memorial Health System) represent 18.1% of annualized base rent.
- Regulatory Risks: Potential reductions in Medicare/Medicaid reimbursement rates and changes in the Affordable Care Act could impact tenant ability to pay rent.
- Geographic Concentration: Significant exposure to Texas (17.0% of ABR), Florida (10.9%), and Ohio (8.0%).
Investor Verification Checklist
- Verify the status of the White Rock Medical Center bankruptcy proceedings and the likelihood of lease affirmation.
- Review the impact of the new interest rate swaps effective May 2026 on future interest expense and FAD.
- Monitor the dividend policy given the reduction in 2025 and the company's reliance on external capital for distributions.
- Assess the financial health of the top three tenants, which collectively account for nearly 20% of rental income.
- Confirm the utilization of the $44 million remaining under the 2025 Share Repurchase Program.